Harvard Medical Faculty Physicians
Neurology
Dr. Daniel R. Tarsy, MD
|
|
Give Review
Daniel Tarsy is an expert in the field of Neurology. He researched medicine at NYU School of Medicine. He over the years received 4 awards: "Meaningful Use Stage 1 Certification", "Boston Magazine", "Super Doctor" and "Top MD". Daniel R. Tarsy, MD is a published MD. He published 98 publications, including: 'Comparison of acute- and delayed-onset posttraumatic cervical dystonia.' Daniel Tarsy accepts all Medicare patients.
Publications
- Phonemic verbal fluency decline after subthalamic nucleus deep brain stimulation does not depend on number of microelectrode recordings or lead tip placement.
- Mobility, mood and site of care impact health related quality of life in Parkinson's Disease.
- Novel use of dual immunomodulation for treating stiff-person Syndrome, cerebellar variant.
- The "floating door sign" in Parkinson's Disease.
- Initial Treatment of Parkinson's Disease: An Update.
- Sternutatory reflex induced by periocular needle insertion in patients receiving chronic botulinum toxin injections.
- Loss of benefit in VIM thalamic deep brain stimulation (DBS) for Essential tremor (ET): How prevalent is it?
- Thalamic and Subthalamic Deep Brain Stimulation for Parkinsonian Tremor: Are Two Circuits Involved?
- Treatment of Parkinson Disease: a 64-year-old man with motor complications of advanced Parkinson Disease.
- Singing in groups for Parkinson's Disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders.
- The effects of blocking catecholamine uptake on amphetamine-induced circling behaviour in mice with unilateral destruction of striatal dopaminergic Nerve terminals.
- Withdrawal Syndromes associated with antipsychotic drugs.
- Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia.
- Letter: Metoclopramide in Parkinsonism.
- Deanol acetamidobenzoate treatment in choreiform movement Disorders.
- The pathophysiologic basis of tardive dyskinesia.
- Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.
- Inhibition of turning behaviour by clozapine in mice with unilateral destruction of dopaminergic Nerve terminals.
- Tardive dyskinesia in young adults.
- The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
- Focal contralateral Myoclonus produced by inhibition of GABA action in the caudate nucleus of rats.
- Physostigmine in Wilson Disease.
- Azorean Disease of the nervous system: report of six additional families.
- Mechanisms underlying tardive dyskinesia.
- Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.
- Unilateral asterixis associated with a mesencephalic Syndrome.
- Metoclopramide and pimozide in Parkinson''s Disease and levodopa-induced dyskinesias.
- Amphetamines in the treatment of Parkinson''s Disease.
- Clonidine in Parkinson Disease.
- Focal Myoclonus produced by injection of picrotoxin into the caudate nucleus of the rat.
- Relationship between animal models and clinical Parkinsonism.
- Rotational behavior induced in rats by intranigral picrotoxin.
- Proceedings: The effect of cholinergic and anticholinergic drugs on rotational behaviour in mice with destruction of one nigrostriatal pathway.
- Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents.
- Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum.
- Does capsaicin relieve the pain of diabetic neuropathy?
- Pseudallescheria boydii infection of the central nervous system.
- Acute transverse myelitis during disseminated cytomegalovirus infection in a renal transplant recipient.
- Cholinergic-adrenergic hypothesis of mania and depression.
- 5-Iodo-2''-deoxyuridine (IUDR; NSC-39661) given intraventricularly in the treatment of Progressive multifocal leukoencephalopathy.
- Glycerol in acute cerebral infarction.
- Physostigmine in choreiform movement Disorders.
- Letter: Deanol in tardive dyskinesia.
- Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.
- Pharmacologically induced behavioural supersensitivity to apomorphine.
- Role of noradrenaline in levodopa reversal of reserpine akinesia.
- Side effects of L-dopa.
- Abbreviated specialty training.
- Pathophysiologic basis of tardive dyskinesia.
- Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
- The current state and needs of north american movement Disorders fellowship programs.
- Clonazepam and phenobarbital in tardive dyskinesia.
- History and definition of tardive dyskinesia.
- Neuroleptic-induced extrapyramidal reactions: classification, description, and diagnosis.
- Tardive dyskinesia.
- Movement Disorders with neuroleptic drug treatment.
- Cat-scratch encephalopathy: a cause of status epilepticus and coma in a healthy young adult.
- Botulinum toxin treatment is not effective for Epilepsy partialis continua.
- Limb Dystonia following electrical injury.
- Stiff-man Syndrome. Report of a case.
- Spontaneous calcific embolization to the supraclinoid internal carotid artery from a regurgitant bicuspid aortic valve.
- Risperidone and neuroleptic malignant Syndrome.
- Botulinum toxin A in the treatment of spasticity: functional implications and patient selection.
- Tardive dystonia after neuroleptic treatment of Tourette''s Syndrome.
- Comparison of clinical rating scales in treatment of cervical Dystonia with botulinum toxin.
- An open-label study of botulinum toxin A for treatment of tardive Dystonia.
- Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical Dystonia.
- High-frequency unilateral thalamic stimulation in the treatment of Essential and parkinsonian tremor.
- Brachial plexus neuropathy after botulinum toxin injection.
- Comparison of acute- and delayed-onset posttraumatic cervical Dystonia.
- Painful cervical Dystonia: clinical features and response to treatment with botulinum toxin.
- Myasthenia gravis after botulinum toxin A for Meige Syndrome.
- Remacemide: current status and clinical applications.
- AbNormalities of spatial and temporal sensory discrimination in writer's cramp.
- A randomized, controlled trial of remacemide for motor fluctuations in Parkinson''s Disease.
- Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular Dystonia.
- Re: polyradiculoneuritis after botulinum toxin therapy for cervical Dystonia.
- Development and initial validation of a screening tool for Parkinson Disease surgical candidates.
- Clinico-immunologic aspects of botulinum toxin type B treatment of cervical Dystonia.
- Laserlight cues for Gait freezing in Parkinson''s disease: an open-label study.
- Cognitive slowing in Parkinson''s Disease resolves after practice.
- Re: parkinsonism and Epilepsy: case report and reappraisal of an old question to the editor.
- Novel THAP1 sequence variants in primary Dystonia.
- Case records of the Massachusetts General Hospital. Case 17-2010 - a 29-year-old woman with flexion of the left hand and foot and difficulty speaking.
- A heteroplasmic mitochondrial complex I gene mutation in adult-onset Dystonia.
- Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy.
- Palmaris brevis spasm: An occupational Syndrome.
- Quantifying muscle asymmetries in cervical Dystonia with electrical impedance: a preliminary assessment.
- A web-based system for home monitoring of patients with Parkinson's Disease using wearable sensors.
- Home monitoring of patients with Parkinson's Disease via wearable technology and a web-based application.
- The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary Dystonia.
- Novel human pathological mutations. Gene symbol: THAP1. Disease: Dystonia 6.
- Novel human pathological mutations. Gene symbol: THAP1. Disease: Dystonia 6.
- Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs.
- Sustained dyskinesias following elective cessation and reactivation of chronic subthalamic nucleus deep brain stimulation for a surgical procedure.
- Survey of U.S. neurologists' attitudes towards deep brain stimulation for Parkinson's Disease.
- Deep-brain stimulation for Dystonia: new twists in assessment.
Schools
New York University
Baltimore City Hosps
Boston University
Institute Psychology
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Non-Cosmetic Chemodenervation
Conditions Treated
- Ataxia
- Carpal Tunnel Syndrome
- Chorea (Excluding Huntington's Chorea)
- Diplopia
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Boston Magazine
- Super Doctor
- Top MD
Education
-
Johns Hopkins Bayview Medical Center -
NYU School of Medicine
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1447281274 | |
| NPPES Provider LastName | TARSY | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 02215 | |
| NPPES Provider State | MA | |
| Specialty Description | Neurology | |
| Total Claim Count | 758.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447281274 |
| Last Name Of The Provider | TARSY |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Katherine T. Dawson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie J. Miller, MD |
|
|
Dr. Andrew S. Lim, MD |
|
|
Dr. Pearl K. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew S. Brock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luisa Solis-Cohen, MD |
|
|
Dr. Dana H. Gabuzda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ferdinando S. Buonanno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin G. Zifkin, MD |
|
|
Dr. Janet L. Jankowiak, MD |
|
|
Dr. Michael G. Ho, MD
This Doctor is OpenDoctor Recommended.
|